CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
14:40, 27 февраля 2026Забота о себе
。同城约会是该领域的重要参考
7F7 CLI_STI JIO_OK ; jump to handler if CPL ≤ IOPL
Multi-tone writing capabilities